Your browser doesn't support javascript.
loading
Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus.
Lee, Chi-Ho; Wu, Mei-Zhen; Lui, David Tak-Wai; Chan, Darren Shing-Hei; Fong, Carol Ho-Yi; Shiu, Sammy Wing-Ming; Wong, Ying; Lee, Alan Chun-Hong; Lam, Joanne King-Yan; Woo, Yu-Cho; Lam, Karen Siu-Ling; Yiu, Kelvin Kai-Hang; Tan, Kathryn Choon-Beng.
Afiliación
  • Lee CH; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Wu MZ; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.
  • Lui DT; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Chan DS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Fong CH; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Shiu SW; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Wong Y; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Lee AC; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Lam JK; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Woo YC; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Lam KS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Yiu KK; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Tan KC; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.
Diabetes Metab J ; 46(6): 843-854, 2022 11.
Article en En | MEDLINE | ID: mdl-35483674

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Diabetes Metab J Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Diabetes Metab J Año: 2022 Tipo del documento: Article País de afiliación: China